Medarex antibodies news

MEDX said a stock option investigation by the board's special investigation committee that started in June has shown that prior to 2002, MEDX "had a practice, in many instances, of dating its stock option grants and restricted stock grants as of dates on

Read the full 435 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE